| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | -2.83% | +0.17% | -3.00% | -5.26% | — |
| 14d | 3 | +100.00% | +2.23% | +1.86% | +0.37% | -3.53% | — |
| 30d | 3 | +33.33% | +40.87% | +1.97% | +38.89% | +40.90% | — |
| 60d | 3 | +33.33% | +44.18% | +4.21% | +39.98% | +24.36% | — |
| 90d | 3 | +33.33% | +36.47% | +3.10% | +33.37% | +24.81% | — |
| 180d | 3 | +33.33% | +85.07% | +4.77% | +80.30% | +82.26% | — |
| 1y | 3 | +33.33% | +114.42% | +12.04% | +102.38% | +102.80% | — |
| 2y | 3 | +0.00% | +34.78% | +37.91% | -3.13% | +17.62% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASE President and CEO | 250,000 | $1.67 | $418.4K | 1,721,298 | Jun 3, 2026 | Jun 5, 2026 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 632,318 | — | — | 632,318 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,880,510 | — | — | 1,880,510 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 809,710 | — | — | 809,710 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE President and CEO | 85,324 | $3.05 | $260.2K | 1,471,298 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE President and CEO | 97,914 | $3.27 | $320.5K | 1,556,622 | Mar 11, 2024 | Mar 12, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,081,201 | — | — | 1,081,201 | Mar 9, 2024 | Mar 12, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASE President and CEO | 192,084 | $0.55 | $106.0K | 1,647,369 | Sep 7, 2023 | Sep 11, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE President and CEO | 73,807 | $7.22 | $532.9K | 1,654,536 | Sep 7, 2023 | Sep 11, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE President and CEO | 48,021 | — | — | 0 | Sep 7, 2023 | Sep 11, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASE President and CEO | 32,953 | $0.55 | $18.2K | 1,680,322 | Sep 7, 2023 | Sep 11, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE President and CEO | 192,084 | — | — | 0 | Sep 7, 2023 | Sep 11, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE President and CEO | 32,953 | — | — | 0 | Sep 7, 2023 | Sep 11, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASE President and CEO | 48,021 | $0.55 | $26.5K | 1,728,343 | Sep 7, 2023 | Sep 11, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 238,750 | — | — | 1,455,285 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 604,308 | — | — | 604,308 | Jul 15, 2022 | Jul 19, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASE President and CEO | 17,700 | $3.36 | $59.5K | 1,216,535 | Jun 23, 2022 | Jun 27, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Mar 30, 2022 | Apr 1, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 207,758 | — | — | 207,758 | Mar 30, 2022 | Apr 1, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 1,198,835 | Mar 30, 2022 | Apr 1, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Apr 12, 2021 | Apr 14, 2021 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,619 | — | — | 948,835 | Apr 12, 2021 | Apr 14, 2021 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 902,216 | Mar 2, 2020 | Mar 4, 2020 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Mar 2, 2020 | Mar 4, 2020 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 450,865 | — | — | 450,865 | Mar 2, 2020 | Mar 4, 2020 ↗ | View → |